Redwood Consultants to Assist with Corporate Communications

ST. PAUL, MN – July 16, 2001 – Hypertension Diagnostics, Inc. (Nasdaq SmallCap: HDII; HDIIW; HDIIU; HDIIZ) announced today that it has retained Redwood Consultants, LLC, a full service investor relations firm based in Marin County, CA, to assist it with corporate communications to the financial community.

 

   
Founded to provide services primarily to SmallCap public companies listed on the NASDAQ, American and NYSE exchanges, the principals of Redwood Consultants each have more than 12 years of professional, Wall Street experience in corporate finance management, investor relations, institutional equity sales and syndicate operations. Mr. Kenneth Brimmer, Chairman of Hypertension Diagnostics’ Board of Directors, said that, "Redwood will be working closely with the company to establish, implement and maintain a corporate communications program that will build and sustain enhanced investor relations and sponsorship." Redwood Consultants facilitate investor relations by communicating directly with retail stockbrokers, institutions, fund managers and analysts, and by assisting with the packaging and dissemination of company materials including press releases and SEC documents.

About Hypertension Diagnostics

Hypertension Diagnostics, Inc. designs, develops, manufactures and markets proprietary cardiovascular profiling systems for clinical and research applications. These systems are marketed to physicians, other health care professionals and researchers by a direct sales force and via distributors throughout the world. In addition to providing blood pressure values, the systems non-invasively detect subtle changes in the compliance or elasticity of both large and small arteries which is a unique feature of HDI’s blood pressure waveform analysis technology. The systems includes a custom designed Arterial PulseWave™ Sensor to capture waveform data as well as a printer which generates a CVProfile™ Report which can assist physicians in their clinical work.

Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company's 2000 Annual Report on Form 10-KSB, as amended, under the caption "Risk Factors," as well as others not now anticipated.

Hypertension Diagnostics, HDI/PulseWave™ and CVProfilor® are trademarks of Hypertension Diagnostics, Inc. All rights reserved.

Contact: Greg H. Guettler, President

Return to the Main HDI Newsroom

   

Back to Top

 

 
     

Copyright © 2010 Hypertension Diagnostics, Inc
Last revised Wednesday June 23, 2010
HDI Legal Information